Cat. No. 4430
Chemical Name: 5-Cyclopropyl-2-[1-[(2-fluorophenyl
Biological ActivityActivator of soluble guanylyl cyclase (sGC); acts at a nitric oxide (NO)-independent regulatory site in the sGC α1 subunit. Inhibits platelet aggregation (IC50 = 36 nM) and phenylephrine-induced contractions of rabbit aorta (IC50 = 0.30 μM). Also reduces vascular smooth muscle growth through cAMP- and cGMP-dependent PKA and PKG pathways.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Joshi et al (2011) The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways. J.Pharmacol.Exp.Ther. 339 394. PMID: 21825001.
Stasch et al (2010) NO-independent regulatory site on soluble guanylate cyclase. Nature 410 212. PMID: 11242081.
Mittendorf et al (2009) Discovery of Riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension. ChemMedChem 4 853. PMID: 19263460.
If you know of a relevant reference for BAY 41-2272 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses BAY 41-2272 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: BAY 41-2272, supplier, activators, soluble, guanylyl, guanylate, cyclases, sGC, BAY41-2272, Tocris Bioscience, Guanylyl Cyclase Activator products